# Effects of Abatacept on Myocarditis in Rheumatoid Arthritis

> **NCT03619876** · PHASE4 · TERMINATED · sponsor: **Columbia University** · enrollment: 11 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Myocardial Inflammation

## Interventions

- **DRUG:** Abatacept
- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT03619876
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-10
- **Primary completion:** 2021-09-15
- **Final completion:** 2021-09-15
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2023-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03619876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03619876, "Effects of Abatacept on Myocarditis in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03619876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*